High ROIC Stocks
MEDP is currently part of our High ROIC Stocks screen, indicating it generates strong returns on invested capital.
MEDPACE HOLDINGS INC (MEDP) Stock Price & Overview
NASDAQ:MEDP • US58506Q1094
Current stock price
498.34 USD
+8.86 (+1.81%)
At close:
498.34 USD
0 (0%)
After Hours:
The current stock price of MEDP is 498.34 USD. Today MEDP is up by 1.81%. In the past month the price increased by 6.17%. In the past year, price increased by 73.57%.
MEDP Key Statistics
52-Week Range250.05 - 628.916
Current MEDP stock price positioned within its 52-week range.
1-Month Range442.83 - 501.24
Current MEDP stock price positioned within its 1-month range.
- Market Cap
- 14.143B
- P/E
- 32.57
- Fwd P/E
- 28.59
- EPS (TTM)
- 15.30
- Dividend Yield
- N/A
MEDP Stock Performance
Today
+1.81%
1 Week
+6.80%
1 Month
+6.17%
3 Months
-12.73%
Longer-term
6 Months -6.41%
1 Year +73.57%
2 Years +28.32%
3 Years +149.00%
5 Years +193.69%
10 Years N/A
MEDP Stock Chart
MEDP Stock Screens
MEDP currently appears in the following ChartMill screener lists.
Revenue Growth Leaders
MEDP is part of our revenue growth leaders stock screen, indicating it has strong recent and multi-year revenue growth.
Fallen Angels Stocks
MEDP part of our Fallen Angels screen, meaning it combines strong fundamentals with recent price weakness that may present an opportunity.
MEDP Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to MEDP. When comparing the yearly performance of all stocks, MEDP is one of the better performing stocks in the market, outperforming 82.62% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
MEDP Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDP. MEDP scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MEDP Earnings
On February 9, 2026 MEDP reported an EPS of 4.67 and a revenue of 708.45M. The company beat EPS expectations (9.56% surprise) and beat revenue expectations (0.75% surprise).
Next Earnings DateApr 22, 2026
Last Earnings DateFeb 9, 2026
PeriodQ4 / 2025
EPS Reported$4.67
Revenue Reported708.45M
EPS Surprise 9.56%
Revenue Surprise 0.75%
MEDP Forecast & Estimates
19 analysts have analysed MEDP and the average price target is 500.23 USD. This implies a price increase of 0.38% is expected in the next year compared to the current price of 498.34.
For the next year, analysts expect an EPS growth of 13.94% and a revenue growth 11.79% for MEDP
Analysts
Analysts70.53
Price Target500.23 (0.38%)
EPS Next Y13.94%
Revenue Next Year11.79%
MEDP Groups
Sector & Classification
MEDP Financial Highlights
Over the last trailing twelve months MEDP reported a non-GAAP Earnings per Share(EPS) of 15.3. The EPS increased by 21.14% compared to the year before.
Income Statements
Revenue(TTM)2.53B
Net Income(TTM)451.12M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.83% | ||
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%27.25%
Sales Q2Q%32.03%
EPS 1Y (TTM)21.14%
Revenue 1Y (TTM)19.97%
MEDP Ownership
Ownership
Inst Owners84.9%
Shares28.38M
Float22.86M
Ins Owners0.51%
Short Float %6.13%
Short Ratio3.83
MEDP Latest News, Press Relases and Analysis
3 days ago - By: Chartmill
MEDP Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.82 | 183.712B | ||
| DHR | DANAHER CORP | 22.51 | 134.915B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.21 | 43.766B | ||
| A | AGILENT TECHNOLOGIES INC | 17.26 | 32.369B | ||
| WAT | WATERS CORP | 20.94 | 29.419B | ||
| IQV | IQVIA HOLDINGS INC | 13.52 | 28.941B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.86 | 25.901B | ||
| ILMN | ILLUMINA INC | 24.35 | 19.362B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.45 | 18.218B | ||
| RVTY | REVVITY INC | 16.13 | 9.829B | ||
| CRL | CHARLES RIVER LABORATORIES | 15.59 | 8.61B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.408B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MEDP
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Company Info
IPO: 2016-08-11
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO 45227 US
CEO: August J. Troendle
Employees: 5900
Phone: 13026587581
MEDPACE HOLDINGS INC / MEDP FAQ
What does MEDP do?
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 5,900 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Can you provide the latest stock price for MEDPACE HOLDINGS INC?
The current stock price of MEDP is 498.34 USD. The price increased by 1.81% in the last trading session.
What is the dividend status of MEDPACE HOLDINGS INC?
MEDP does not pay a dividend.
How is the ChartMill rating for MEDPACE HOLDINGS INC?
MEDP has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Should I buy MEDP stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MEDP.
What is the employee count for MEDP stock?
MEDPACE HOLDINGS INC (MEDP) currently has 5900 employees.
What is MEDPACE HOLDINGS INC worth?
MEDPACE HOLDINGS INC (MEDP) has a market capitalization of 14.14B USD. This makes MEDP a Large Cap stock.